Please login to the form below

Not currently logged in
Email:
Password:

omalizumab

This page shows the latest omalizumab news and features for those working in and with pharma, biotech and healthcare.

AZ prices severe asthma drug Fasenra below competition

AZ prices severe asthma drug Fasenra below competition

Along with Nucala and Cinqair, severe asthma patients can also be treated with Novartis’older drug Xolair (omalizumab), although that is indicated for allergic asthma and doesn’t specifically address eosinophilic

Latest news

More from news
Approximately 8 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics